rs775932562
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_176787.5(PIGN):c.1766A>G(p.Lys589Arg) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.0000244 in 1,599,504 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. K589K) has been classified as Likely pathogenic.
Frequency
Consequence
NM_176787.5 missense, splice_region
Scores
Clinical Significance
Conservation
Publications
- multiple congenital anomalies-hypotonia-seizures syndrome 1Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P, Orphanet, ClinGen, PanelApp Australia
- Fryns syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| PIGN | NM_176787.5 | c.1766A>G | p.Lys589Arg | missense_variant, splice_region_variant | Exon 19 of 31 | ENST00000640252.2 | NP_789744.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| PIGN | ENST00000640252.2 | c.1766A>G | p.Lys589Arg | missense_variant, splice_region_variant | Exon 19 of 31 | 1 | NM_176787.5 | ENSP00000492233.1 | ||
| PIGN | ENST00000400334.7 | c.1766A>G | p.Lys589Arg | missense_variant, splice_region_variant | Exon 18 of 30 | 1 | ENSP00000383188.2 | |||
| PIGN | ENST00000638424.1 | n.1766A>G | splice_region_variant, non_coding_transcript_exon_variant | Exon 17 of 29 | 5 | ENSP00000491963.1 |
Frequencies
GnomAD3 genomes AF: 0.0000920 AC: 14AN: 152186Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000389 AC: 9AN: 231270 AF XY: 0.0000320 show subpopulations
GnomAD4 exome AF: 0.0000173 AC: 25AN: 1447318Hom.: 0 Cov.: 28 AF XY: 0.0000153 AC XY: 11AN XY: 719020 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000920 AC: 14AN: 152186Hom.: 0 Cov.: 32 AF XY: 0.000121 AC XY: 9AN XY: 74342 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Multiple congenital anomalies-hypotonia-seizures syndrome 1 Uncertain:2
This sequence change replaces lysine, which is basic and polar, with arginine, which is basic and polar, at codon 589 of the PIGN protein (p.Lys589Arg). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This variant has not been reported in the literature in individuals affected with PIGN-related conditions. ClinVar contains an entry for this variant (Variation ID: 569845). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
- -
Inborn genetic diseases Uncertain:1
The c.1766A>G (p.K589R) alteration is located in exon 19 (coding exon 16) of the PIGN gene. This alteration results from a A to G substitution at nucleotide position 1766, causing the lysine (K) at amino acid position 589 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
not provided Uncertain:1
In silico analysis indicates that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at